PEP, Carlyle weigh iNova sale pitched with $150m-plus EBITDA
MELBOURNE: Private equity-owned medicine and healthcare products company iNova Pharmaceuticals is back up ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
